New emerging roles of the novel hepatokine SERPINB1 in type 2 diabetes mellitus: Crosstalk with β-cell dysfunction and dyslipidemia
Mohamed M. Kamal, Aya Adel, Ghada H. Sayed, Shadia Ragab, Dina H. Kassem
Topics & Concepts
DyslipidemiaInsulin resistanceMedicineInternal medicineType 2 Diabetes MellitusGlycemicEndocrinologyDiabetes mellitusLipid profileType 2 diabetesInsulinMetabolism, Diabetes, and CancerAdipokines, Inflammation, and Metabolic DiseasesPancreatic function and diabetes